Literature DB >> 7632813

A 37-year-old man with cholestatic jaundice and a prior history of Hodgkin's disease.

M Hoogendoorn1, J H van Krieken, R Bieger.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7632813     DOI： 10.1007/bf01696620

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  14 in total

1.  Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?

Authors:  J T Sundeen; J Cossman; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

2.  Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

Authors:  M Tubiana; M Henry-Amar; P Carde; J M Burgers; M Hayat; E Van der Schueren; E M Noordijk; A Tanguy; J H Meerwaldt; J Thomas
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

3.  Major complications and causes of death in patients treated for Hodgkin's disease.

Authors:  R E van Rijswijk; J Verbeek; C Haanen; A W Dekker; W A van Daal; H A van Peperzeel
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

4.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.

Authors:  J G Krikorian; J S Burke; S A Rosenberg; H S Kaplan
Journal:  N Engl J Med       Date:  1979-03-01       Impact factor: 91.245

5.  Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation.

Authors:  M H Bennett; K A MacLennan; G Vaughan Hudson; B Vaughan Hudson
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

6.  Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

7.  Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.

Authors:  P Mauch; N Tarbell; H Weinstein; B Silver; T Goffman; R Osteen; A Zajac; C N Coleman; G Canellos; D Rosenthal
Journal:  J Clin Oncol       Date:  1988-10       Impact factor: 44.544

8.  Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.

Authors:  F E van Leeuwen; R Somers; B G Taal; P van Heerde; B Coster; T Dozeman; S J Huisman; A A Hart
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

9.  Long-term results of curative irradiation in pathologically staged IA and IIA Hodgkin disease.

Authors:  W F Hartsell; P Sarin; D C Recine; L J Kazlauskas; D L Galinsky; K L Griem; V S Saxena; A K Murthy
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

10.  Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study.

Authors:  S Poppema; E Kaiserling; K Lennert
Journal:  Histopathology       Date:  1979-07       Impact factor: 5.087
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.